entertainment -WSS

entertainment

author：explore 2025-09-30 20:18:33 - browse：623

A DNA helix, with dollar banknotes covering its strands, collapses next to another DNA helix with dollar banknotes strands — coverage from STAT — Adobe

The closely watched gene-editing startup Prime Medicine is embroiled in a multimillion-dollar dispute with another biotech it partnered with to develop a potentially powerful new form of genome editing.

Prime and Myeloid Therapeutics, a startup co-founded by Pulitzer Prize-winning writer and cancer biologist Siddhartha Mukherjee, have filed competing arbitration claims over a deal they signed in March 2022.

Prime, spun out of the lab of Broad Institute biochemist David Liu, was built on technology for making small insertions, deletions, and single-letter changes in DNA. In theory, prime editing allows researchers to tackle the vast majority of disease-causing mutations, and the first treatments are already being readied for clinical trials. But it’s a poor fit in cases where hundreds or even thousands of different mutations in a long gene cause the same diseases, such as cystic fibrosis or Duchenne muscular dystrophy.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Scientists boost immune system in aging mice by making it youthful

WSS

Readout LOUD podcast: mifepristone case, GLP

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Abortion pill case raises question: who can sue the FDA?

States should stop sabotaging methadone treatment reform

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Steward Health Care has deal to sell doctor network to UnitedHealth

Wikipedia

entertainment

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Why you shouldn’t ask, “What country has the best health care?”

Guidelines to prevent youth baseball injuries need more muscle

FDA's naming rule on biosimilars has undermined competition

As demand for Covid shots wanes, Moderna seeks its next success

Study says nonprofit hospitals fall short in charity care spending

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Merck drug for rare lung condition set for approval in U.S.

New air purifier tech could be key to improving indoor air quality

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

leisure time

FTC sues over Novant Health acquisition of two N.C. hospitals

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

FTC sues over Novant Health acquisition of two N.C. hospitals

Primary care physicians play key roles in Alzheimer's management

Decaf coffee targeted by food safety group under obscure FDA rule

States should stop sabotaging methadone treatment reform

Wikipedia

hotspot

explore

explore